Clinical Trials for ARQ 197 (Tivantinib)

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticECOGUROS1107
03/08/2013
Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination with Erlotinib in Papillary Renal Cell Carcinoma
TherapeuticVICCPHI1185
05/15/2012
An Extension Protocol for Subjects who were Previously Enrolled in Other ARQ 197 Protocols

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.